Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Using Hybrid-ESD+ and LiftUp® as Injectable on en Bloc/R0 Rate in Colorectal Adenomas Between 2 and 3 cm.

NCT05517369 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT05517369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05517369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Using Hybrid-ESD+ and LiftUp® as Injectable on en Bloc/R0 Rate in Colorectal Adenomas Between 2 and 3 cm.
Lead sponsor
Wuerzburg University Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
March 1, 2023
Completion date
October 31, 2024
Enrollment
0 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma